Inventor · disambiguated record
Thomas Andrew Wynn
Also filed as: WYNN THOMAS · WYNN THOMAS A · WYNN THOMAS ANDREW
42 granted patents·13 pending applications·356 citations·filing 1999–2024
98Inventor score
Files withALKERMES PHARMA IRELAND LTD32ALKERMES INC4ACCENT THERAPEUTICS INC3MILLENNIUM PHARM INC3IKENA ONCOLOGY INC2
Top patents by PatentIndex Score
55 records- 0198US9090558B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Jul 28, 2015·38 cites·2 claims
- 0298US8669281B1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2013·Granted Mar 11, 2014·97 cites·4 claims
- 0395US9682936B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Jun 20, 2017·14 cites·24 claims
- 0495US9416137B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Aug 16, 2016·15 cites·17 claims
- 0593US2025127747A1Prodrugs of Fumarates and Their Use in Treating Various DiseasesALKERMES PHARMA IRELAND LTD·Filed 2024·Application pending·0 cites
- 0692US11083703B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Aug 10, 2021·2 cites·4 claims
- 0792US10752592B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Aug 25, 2020·8 cites·9 claims
- 0892US10736890B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Aug 11, 2020·8 cites·6 claims
- 0992US10287250B2Morphan and morphinan analogues, and methods of useALKERMES PHARMA IRELAND LTD·Filed 2017·Granted May 14, 2019·8 cites·24 claims
- 1092US10231963B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Mar 19, 2019·8 cites·9 claims
- 1192US9775823B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Oct 3, 2017·8 cites·12 claims
- 1292US9656961B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2014·Granted May 23, 2017·14 cites·19 claims
- 1392US9505776B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2014·Granted Nov 29, 2016·10 cites·8 claims
- 1490US12076306B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2023·Granted Sep 3, 2024·0 cites·4 claims
- 1590US10596140B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Mar 24, 2020·4 cites·4 claims
- 1688US2024300969A1Prodrugs of Fumarates and Their Use in Treating Various DiseasesALKERMES PHARMA IRELAND LTD·Filed 2024·Application pending·0 cites
- 1787US7282206B2Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chainsUS HEALTH·Filed 2003·Granted Oct 16, 2007·24 cites·34 claims
- 1886US6664227B1Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chainsINST GENETICS LLC·Filed 1999·Granted Dec 16, 2003·61 cites·32 claims
- 1984US7968536B2Heterocyclic compounds useful as RAF kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Jun 28, 2011·9 cites·31 claims
- 2082US12257249B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2022·Granted Mar 25, 2025·0 cites·15 claims
- 2181US11905298B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Feb 20, 2024·0 cites·2 claims
- 2281US10604489B2Compounds for the treatment of painALKERMES INC·Filed 2019·Granted Mar 31, 2020·1 cites·16 claims
- 2381US10406133B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Sep 10, 2019·1 cites·4 claims
- 2481US8802657B2Compounds useful as Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2012·Granted Aug 12, 2014·4 cites·19 claims
- 2580US11679092B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Jun 20, 2023·0 cites·4 claims
- 2680US8293752B2Compounds useful as Raf kinase inhibitorsCHEN WEIRONG·Filed 2008·Granted Oct 23, 2012·6 cites·13 claims
- 2779US7910105B2Methods for treating and preventing fibrosisWYETH LLC·Filed 2006·Granted Mar 22, 2011·3 cites·8 claims
- 2879US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 2978US9604922B2Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Mar 28, 2017·2 cites·31 claims
- 3075US12009478B1Solid state electrolyteRIVIAN IP HOLDINGS LLC·Filed 2023·Granted Jun 11, 2024·0 cites·8 claims
- 3175US11230548B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Jan 25, 2022·0 cites·4 claims
- 3274US10189855B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Jan 29, 2019·0 cites·14 claims
- 3372US12459895B2MEK inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 3472US11534436B2Methods for treating depressive symptomsALKERMES PHARMA IRELAND LTD·Filed 2020·Granted Dec 27, 2022·0 cites·17 claims
- 3570US2019382413A1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2018·Application pending·0 cites
- 3669US10080733B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Sep 25, 2018·0 cites·4 claims
- 3769US2022033394A1Compounds for the treatment of painALKERMES INC·Filed 2021·Application pending·0 cites
- 3868US11878958B2MEK inhibitors and uses thereofIKENA ONCOLOGY INC·Filed 2023·Granted Jan 23, 2024·0 cites·22 claims
- 3968US10117846B2Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2017·Granted Nov 6, 2018·0 cites·10 claims
- 4067US11180455B2Compounds for the treatment of painALKERMES INC·Filed 2020·Granted Nov 23, 2021·0 cites·16 claims
- 4166US12188116B2Free-standing lithium phosphorus oxynitride think films and methods of their manufactureUNIV CALIFORNIA·Filed 2021·Granted Jan 7, 2025·0 cites·20 claims
- 4262US2016137660A1Prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 4361US10975099B2Thiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Apr 13, 2021·0 cites·17 claims
- 4460US10807995B2Thienothiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 20, 2020·0 cites·13 claims
- 4555US9920048B2Substituted pyrimidines for inhibiting Raf kinase activityMILLENNIUM PHARM INC·Filed 2016·Granted Mar 20, 2018·0 cites·13 claims
- 4653US2024051985A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4751US2006074243A1Hydroxamic acid and amide compounds and their use as protease inhibitorsPHARMACIA ITALIA SPA·Filed 2005·Application pending·0 cites
- 4849US10301256B2Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseasesALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 28, 2019·0 cites·15 claims
- 4949US2023027361A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5049US2004167182A1Hydroxamic acid and amide compounds and their use as protease inhibitorsFiled 2003·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Andrew Wynn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →